Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 64
Filter
1.
Res Vet Sci ; 135: 27-35, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33422729

ABSTRACT

The intake of antinutritional factors produce impairment on the intestinal digestive function, impeding the efficient use of nutrients. Probiotics could be useful in poultry breeding to prevent negative effects of antinutritional factors, like the dietary lectins soybean agglutinin (SBA) and wheat germ agglutinin (WGA). Therefore, this investigation aimed to verify that SBA and wheat, which contains WGA, exert harmful effects on the intestinal mucosa and the digestive system of young poultry, and determine if the administration of probiotics able to capture lectins could counteract their effects. The trials performed demonstrated that a mixture of Bifidobacterium infantis CRL 1395, Enterococcus faecium LET 301, Lactobacillus salivarius LET 201, L. reuteri LET 210, and Propionibacterium acidipropionici LET 103, strains with ex vivo ability to interfere with the interaction of lectins and epithelial cells, has no negative effect on young chickens health. Middle levels of SBA, as well as wheat as a source of WGA, resulted in lower activities of intestinal and brush border enzymes and alterations in the integrity and morphological parameters of the chicks jejunal mucosa. The bacteria blend increased the activity of several digestive enzymes and the intestinal maturation marker alkaline phosphatase in birds fed with a conventional diet. Besides, it partially countered the deleterious effects of increased content of SBA, as well as the negative effect of a dietary source of WGA, on digestive enzymes activity and intestinal mucosa integrity. The results highlight the capability of multifunctional bacterial mixtures to protect the digestive system of avian against residual dietary lectins.


Subject(s)
Chickens , Diet/veterinary , Intestinal Mucosa/drug effects , Intestinal Mucosa/microbiology , Lectins/adverse effects , Probiotics/pharmacology , Animal Feed/analysis , Animals , Bacteria , Epithelial Cells/drug effects , Intestinal Mucosa/pathology , Lectins/administration & dosage , Lectins/pharmacology
2.
Nutrients ; 12(10)2020 Sep 24.
Article in English | MEDLINE | ID: mdl-32987890

ABSTRACT

Plant-based diets are associated with reduced risk of lifestyle-induced chronic diseases. The thousands of phytochemicals they contain are implicated in cellular-based mechanisms to promote antioxidant defense and reduce inflammation. While recommendations encourage the intake of fruits and vegetables, most people fall short of their target daily intake. Despite the need to increase plant-food consumption, there have been some concerns raised about whether they are beneficial because of the various 'anti-nutrient' compounds they contain. Some of these anti-nutrients that have been called into question included lectins, oxalates, goitrogens, phytoestrogens, phytates, and tannins. As a result, there may be select individuals with specific health conditions who elect to decrease their plant food intake despite potential benefits. The purpose of this narrative review is to examine the science of these 'anti-nutrients' and weigh the evidence of whether these compounds pose an actual health threat.


Subject(s)
Diet, Vegetarian , Nutrients , Phytochemicals/administration & dosage , Phytochemicals/adverse effects , Antioxidants/administration & dosage , Antioxidants/adverse effects , Antioxidants/analysis , Antithyroid Agents/administration & dosage , Antithyroid Agents/adverse effects , Antithyroid Agents/analysis , Cooking , Food Handling , Fruit/chemistry , Humans , Lectins/administration & dosage , Lectins/adverse effects , Lectins/analysis , Oxalates/administration & dosage , Oxalates/adverse effects , Oxalates/analysis , Phytic Acid/administration & dosage , Phytic Acid/adverse effects , Phytic Acid/analysis , Phytochemicals/analysis , Phytoestrogens/administration & dosage , Phytoestrogens/adverse effects , Phytoestrogens/analysis , Tannins/administration & dosage , Tannins/adverse effects , Tannins/analysis , Vegetables/chemistry
3.
World J Gastroenterol ; 25(24): 2973-2976, 2019 Jun 28.
Article in English | MEDLINE | ID: mdl-31293334

ABSTRACT

Until recently, with the exception of coeliac disease, gastroenterologists have not been particularly interested in the role of diet in the management of gastrointestinal disorders. However, patients have always felt that diet must play a part in their symptoms and, in the absence of any medical interest, have turned to alternative dietary practitioners for help, which can often have no evidence base. Fortunately, with the advent of the FODMAP diet (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) and the realisation that diet can have a profound effect on the microbiome, medical opinion is now changing. Nevertheless, research on the various diets that are now available is often completely lacking. Lectins are carbohydrate binding proteins which are widely distributed in nature and are found in a whole variety of commonly consumed foods. It seems likely that the exclusion of lectins from the diet could become the next "food fashion" for alternative practitioners to promote, especially as there is some evidence to suggest that certain lectins may be harmful to health. It is, therefore, the purpose of this viewpoint to try and stimulate research on the dietary effects of lectins, which is currently minimal, so that we can pre-empt a situation where we are unable to give patients or the public evidence based advice on this topic.


Subject(s)
Diet Fads , Diet, Protein-Restricted/adverse effects , Dietary Proteins/adverse effects , Gastrointestinal Diseases/diet therapy , Lectins/adverse effects , Complementary Therapies/methods , Complementary Therapies/trends , Diet, Carbohydrate-Restricted/adverse effects , Diet, Carbohydrate-Restricted/methods , Diet, Protein-Restricted/methods , Dietary Proteins/administration & dosage , Glutens/administration & dosage , Glutens/adverse effects , Humans , Lectins/administration & dosage , Monosaccharides/administration & dosage , Monosaccharides/adverse effects , Oligosaccharides/administration & dosage , Oligosaccharides/adverse effects
4.
Clin Chim Acta ; 482: 65-73, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29604259

ABSTRACT

BACKGROUND: Complement has been suggested to be involved in diabetic nephropathy (DN), but the exact significance and underlying mechanisms remain unclear. Data about renal local complement activation in DN patients is scarce. The purpose of the study was to clarify the significance and mechanism of renal local complement activation in DN. METHODS: Sixty-two biopsy-proven DN patients were recruited. Renal expression of C1Q, factor B, C5b-9, MBL and MBL-associated serine protease 1 (MASP1) were detected and associated with the kidney damage. RESULTS: C5b-9, MBL and MASP1 was found to increase with the progression of DN. Especially, the level of C5b-9, MBL and MASP1 in tubular interstitium was closely associated with the damage degree of tubular interstitium. In addition, MBL and MASP1 co-localized and their levels in tubular interstitium correlated with the levels of C5b-9 in tubules and tubular interstitium. CONCLUSION: Increased renal local complement activation was present in DN patients and might contribute to the kidney damage, especially tubular interstitial damage. MBL pathway might play an important role in renal tubular interstitial complement activation. Methods against complement activation or MBL pathway might be effective in reducing renal tubular interstitial damage in DN patients.


Subject(s)
Complement Activation/drug effects , Diabetic Nephropathies/etiology , Kidney Tubules/injuries , Kidney/immunology , Lectins/adverse effects , Biopsy , Complement Membrane Attack Complex/metabolism , Diabetic Nephropathies/metabolism , Humans , Mannose-Binding Lectin/metabolism , Mannose-Binding Protein-Associated Serine Proteases/metabolism
5.
In Vitro Cell Dev Biol Anim ; 53(8): 691-698, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28699138

ABSTRACT

The fungal lectin purified from Sclerotinia sclerotiorum, further referred to as Sclerotinia sclerotiorum agglutinin or SSA, possesses insecticidal activity against important pest insects such as pea aphids (Acyrthosiphon pisum). This paper aims at a better understanding of its activity at cellular level. Therefore, different insect cell lines were treated with SSA. These cell lines were derived from different tissues and represent the three major orders of insects important in agriculture: CF-203 (midgut Choristoneura fumiferana, Lepidoptera), GUTAW1 (midgut, Helicoverpa zea, Lepidoptera), High5 cells (ovary, Trichoplusia ni, Lepidoptera), Sf9 (ovary cells from Spodoptera frugiperda, Lepidoptera), S2 (hemocyte, Drosophila melanogaster, Diptera), and TcA (whole body, Tribolium castaneum, Coleoptera). Although the sensitivity to SSA differs between the cell lines, SSA clearly showed toxicity in all six cell lines with median effect concentrations (EC50) ranging between 9 and 42 µg/ml. An in-depth analysis of the mechanism of uptake in the cells revealed superior amounts of FITC-SSA at the membrane of CF-203 cells compared to Sf9 cells, while a similar small amount of SSA was internalized in both cell lines. Pre-incubation with the clathrin-mediated endocytosis inhibitor phenylarsine oxide inhibited the internalization of SSA into the CF-203 and Sf9 cells with a respective reduction of 6- and 1.7-fold. The data are discussed in relation to the importance of cellular uptake mechanism for SSA binding and cytotoxicity.


Subject(s)
Agglutinins/pharmacology , Cell Proliferation/drug effects , Insecta/cytology , Lectins/pharmacology , Agglutinins/adverse effects , Agglutinins/chemistry , Animals , Aphids/cytology , Aphids/drug effects , Ascomycota/chemistry , Cell Line/drug effects , Cell Membrane/chemistry , Cell Membrane/drug effects , Drosophila melanogaster/cytology , Lectins/adverse effects , Lectins/chemistry
6.
Phytomedicine ; 23(1): 32-41, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26902405

ABSTRACT

BACKGROUND: Stenodactylin is a highly toxic plant lectin purified from the caudex of Adenia stenodactyla, with molecular structure, intracellular routing and enzyme activity similar to those of ricin, a well-known type 2 ribosome-inactivating protein. However, in contrast with ricin, stenodactylin is retrogradely transported not only in peripheral nerves but also in the central nervous system. PURPOSE: Stenodactylin properties make it a potential candidate for application in neurobiology and in experimental therapies against cancer. Thus, it is necessary to better clarify the toxic activity of this compound. STUDY DESIGN: We investigated the mechanism of stenodactylin-induced cell death in the neuroblastoma-derived cell line, NB100, evaluating the implications of different death pathways and the involvement of oxidative stress. METHODS: Stenodactylin cytotoxicity was determined by evaluating protein synthesis and other viability parameters. Cell death pathways and oxidative stress were analysed through flow cytometry and microscopy. Inhibitors of apoptosis, oxidative stress and necroptosis were tested to evaluate their protective effect against stenodactylin cytotoxicity. RESULTS: Stenodactylin efficiently blocked protein synthesis and reduced the viability of neuroblastoma cells at an extremely low concentration and over a short time (1 pM, 24 h). Stenodactylin induced the strong and rapid activation of apoptosis and the production of free radicals. Here, for the first time, a complete and long lasting protection from the lethal effect induced by a toxic type 2 ribosome-inactivating protein has been obtained by combining the caspase inhibitor Z-VAD-fmk, to either the hydrogen peroxide scavenger catalase or the necroptotic inhibitor necrostatin-1. CONCLUSION: In respect to stenodactylin cytotoxicity, our results: (i) confirm the high toxicity to nervous cells, (ii) indicate that multiple cell death pathways can be induced, (iii) show that apoptosis is the main death pathway, (iv) demonstrate the involvement of necroptosis and (v) oxidative stress.


Subject(s)
Apoptosis/drug effects , Caspase Inhibitors/pharmacology , Catalase/pharmacology , Imidazoles/pharmacology , Indoles/pharmacology , Lectins/adverse effects , N-Glycosyl Hydrolases/adverse effects , Neuroblastoma/pathology , Amino Acid Chloromethyl Ketones/pharmacology , Caspases/metabolism , Cell Death/drug effects , Cell Line, Tumor/drug effects , Humans , Oxidative Stress , Reactive Oxygen Species/metabolism
7.
Glycobiology ; 24(11): 1010-21, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24973254

ABSTRACT

Previous studies indicate that snake venom contains glycan-binding proteins (GBPs), although the binding specificity and biological activities of many of these GBPs is unclear. Here we report our studies on the glycan binding specificity and activities of galatrox, a Bothrops atrox snake venom-derived GBP. Glycan microarray analysis indicates that galatrox binds most strongly to glycans expressing N-acetyllactosamine (LacNAc), with a significant preference for Galß1-4GlcNAcß over Galß1-3GlcNAcß compounds. Galatrox also bound immobilized laminin, a LacNAc-dense extracellular matrix component, suggesting that this GBP can bind LacNAc-bearing glycoproteins. As several endogenous mammalian GBPs utilize a similar binding LacNAc binding preference to regulate neutrophil and monocyte activity, we hypothesized that galatrox may mediate B. atrox toxicity through regulation of leukocyte activity. Indeed, galatrox bound neutrophils and promoted leukocyte chemotaxis in a carbohydrate-dependent manner. Similarly, galatrox administration into the mouse peritoneal cavity induced significant neutrophil migration and the release of pro-inflammatory cytokines IL-1α and IL-6. Exposure of bone marrow-derived macrophages to galatrox induced generation of pro-inflammatory mediators IL-6, TNF-α, and keratinocyte-derived chemokine. This signaling by galatrox was mediated via its carbohydrate recognition domain by activation of the TLR4-mediated MyD88-dependent signaling pathway. These results indicate that galatrox has pro-inflammatory activity through its interaction with LacNAc-bearing glycans on neutrophils, macrophages and extracellular matrix proteins and induce the release of pro-inflammatory mediators.


Subject(s)
Crotalid Venoms/chemistry , Inflammation/chemically induced , Lectins/metabolism , Polysaccharides/metabolism , Viper Venoms/metabolism , Animals , Bothrops , Carbohydrate Sequence , Lectins/adverse effects , Lectins/chemistry , Molecular Sequence Data , Viper Venoms/adverse effects , Viper Venoms/chemistry
8.
J Nat Med ; 67(2): 247-54, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22645079

ABSTRACT

The Tn antigen (GalNAc-O-Ser/Thr) is one of the most specific human cancer-associated structures. In the present study we characterize the biochemical and functional properties of the Myrsine coriacea lectin (McL). We show that McL is an unusual high molecular weight highly glycosylated protein, which displays a strong Tn binding activity. The lectin exhibits in vitro inhibition of proliferation in the six cancer cell lines evaluated, in a dose-dependent manner (the strongest activity being against HT-29 and HeLa cells), whereas it does not exhibit toxicity against normal lymphocytes. McL could be exploited in the design of potential new tools for the diagnosis or treatment of cancer.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/metabolism , Lectins/metabolism , Lectins/pharmacology , Primulaceae/chemistry , Antineoplastic Agents/adverse effects , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , HT29 Cells , HeLa Cells , Humans , Lectins/adverse effects , Lymphocytes/drug effects
9.
Mar Drugs ; 10(7): 1476-1497, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22851920

ABSTRACT

The development and use of topical microbicides potentially offers an additional strategy to reduce the spread of the Human Immunodeficiency Virus (HIV). Carbohydrate-binding agents (CBAs) that show specificity for high mannose carbohydrates on the surface of the heavily glycosylated envelope of HIV are endowed with potent anti-HIV activity. In fact, a number of algal lectins such as cyanovirin-N, microvirin, microcystis viridis lectin, scytovirin, Oscillatoria agardhii agglutinin and griffithsin are considered as potential microbicide candidates to prevent the sexual transmission of HIV through topical applications. They not only inhibit infection of cells by cell-free virus but they can also efficiently prevent virus transmission from virus-infected cells to uninfected CD4(+) target T-lymphocytes and DC-SIGN-directed capture of HIV-1 and transmission to CD4(+) T lymphocytes. This review focuses on the structural properties and carbohydrate specificity of these algal lectins, their antiviral activity against HIV and several other enveloped viruses, their safety profile and viral resistance patterns.


Subject(s)
Algal Proteins/pharmacology , Anti-HIV Agents/pharmacology , Lectins/pharmacology , Amino Acid Sequence , Bacterial Proteins/pharmacology , Carbohydrates/chemistry , Carrier Proteins/pharmacology , Chrysophyta/chemistry , Cyanobacteria/chemistry , Drug Resistance, Viral , Lectins/adverse effects , Lectins/chemistry , Mannose-Binding Lectin/pharmacology , Molecular Sequence Data , Rhodophyta/chemistry , Sexually Transmitted Diseases/drug therapy
10.
PLoS One ; 6(8): e22635, 2011.
Article in English | MEDLINE | ID: mdl-21829638

ABSTRACT

Many natural product-derived lectins such as the red algal lectin griffithsin (GRFT) have potent in vitro activity against viruses that display dense clusters of oligomannose N-linked glycans (NLG) on their surface envelope glycoproteins. However, since oligomannose NLG are also found on some host proteins it is possible that treatment with antiviral lectins may trigger undesirable side effects. For other antiviral lectins such as concanavalin A, banana lectin and cyanovirin-N (CV-N), interactions between the lectin and as yet undescribed cellular moieties have been reported to induce undesirable side effects including secretion of inflammatory cytokines and activation of host T-cells. We show that GRFT, unlike CV-N, binds the surface of human epithelial and peripheral blood mononuclear cells (PBMC) through an exclusively oligosaccharide-dependent interaction. In contrast to several other antiviral lectins however, GRFT treatment induces only minimal changes in secretion of inflammatory cytokines and chemokines by epithelial cells or human PBMC, has no measureable effect on cell viability and does not significantly upregulate markers of T-cell activation. In addition, GRFT appears to retain antiviral activity once bound to the surface of PBMC. Finally, RNA microarray studies show that, while CV-N and ConA regulate expression of a multitude of cellular genes, GRFT treatment effects only minimal alterations in the gene expression profile of a human ectocervical cell line. These studies indicate that GRFT has an outstanding safety profile with little evidence of induced toxicity, T-cell activation or deleterious immunological consequence, unique attributes for a natural product-derived lectin.


Subject(s)
Algal Proteins/pharmacology , Anti-Infective Agents/pharmacology , Lectins/pharmacology , T-Lymphocytes/drug effects , Adult , Algal Proteins/adverse effects , Anti-Infective Agents/adverse effects , Cell Proliferation/drug effects , Cervix Uteri/cytology , Cervix Uteri/drug effects , Chemokines/metabolism , Cytokines/metabolism , Female , Flow Cytometry , Humans , Lectins/adverse effects , Lymphocyte Activation , Microscopy, Fluorescence , Plant Lectins , T-Lymphocytes/immunology , Vagina/cytology , Vagina/drug effects
11.
Int Immunopharmacol ; 11(10): 1510-5, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21609786

ABSTRACT

The immunoregulatory effect of Artin M and jacalin from extract of Artocarpus integrifolia seeds (jack extract) against infection with Candida albicans was investigated. Swiss mice received jack extract containing 500 µg protein/ml PBS intraperitoneally (i.p.) or PBS alone and after 72 h were infected i.p. with C. albicans CR15 (10(7)) and sacrificed after 30 min, 2, 6, 24, and 72 h. ELISA analysis revealed that in jack extract-treated mice IFN-γ was predominantly produced versus IL-10 in control mice. These results suggest that jack extract induced a protective immune response, since C. albicans clearance was complete at 72 h postinfection. Jack extract presents two lectins (Artin M and jacalin) with distinct biological properties. Artin M was able to induce IL-12 production by macrophages. Also, Artin M in different concentrations, associated with jacalin or in jack extract induced both IFN-γ and IL-17 production. As a consequence, phagocytic and candidacidal activity increased significantly. Alanine aminotransferase activity (ALT) was used as parameter for damage of the liver. The activity of ALT correlated with inoculum size that increased significantly in control group, however, mice pretreated with jack extract 3 days before infection presented normal ALT. Mice pretreated with jack extract that received a lethal inoculum of Candida presented 90% survival versus 20% among controls or mice pretreated with jacalin. Thus, the results suggest that Artin M by itself, associated with jacalin or present in jack extract is able to induce protective Th1 and Th17 immune responses against Candida albicans infection.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Candida albicans/immunology , Candidiasis/immunology , Phytotherapy , Plant Extracts/administration & dosage , Plant Lectins/administration & dosage , Th1 Cells/drug effects , Th17 Cells/drug effects , Adjuvants, Immunologic/adverse effects , Alanine Transaminase/genetics , Alanine Transaminase/immunology , Alanine Transaminase/metabolism , Animals , Artocarpus/immunology , Candida albicans/pathogenicity , Candidiasis/prevention & control , Cytokines/genetics , Cytokines/immunology , Cytokines/metabolism , Enzyme Activation/drug effects , Gene Expression Regulation/drug effects , Gene Expression Regulation/immunology , Immunity/drug effects , Lectins/administration & dosage , Lectins/adverse effects , Mice , Plant Extracts/adverse effects , Plant Lectins/adverse effects , Seeds , Th1 Cells/immunology , Th1 Cells/metabolism , Th1 Cells/pathology , Th17 Cells/immunology , Th17 Cells/metabolism , Th17 Cells/pathology
12.
Ann Rheum Dis ; 69(9): 1655-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-19778914

ABSTRACT

BACKGROUND: Autoantigen-specific immunotherapy by mucosal tolerance induction via the intranasal route is an attractive therapeutic option for the treatment of autoimmune diseases, including rheumatoid arthritis (RA). Human cartilage glycoprotein-39 (HC gp-39) has been identified as a potential key autoantigen in RA. Based on animal studies, intranasal administration of the autoantigen is hypothesised to induce immunological tolerance in patients with RA and to ameliorate disease activity. In a phase I/IIA clinical trial in patients with RA, intranasal application of HC gp-39 was safe and well tolerated. OBJECTIVE: To investigate the efficacy of intranasally administered fully human, recombinant HC gp-39 (Org 39141) by a large clinical study. METHODS: In a 13-week multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding, proof-of-concept trial, patients with RA (disease-modifying antirheumatic drug (DMARD) naive or after washout of DMARD treatment) were randomised to receive either intranasal applications of placebo or HC gp-39 in doses of 30, 150, 300 or 600 microg, once a week. The primary efficacy variable was the 28 joint count Disease Activity Score (DAS28). RESULTS: During the treatment period the DAS28 decreased similarly for all treatment groups-including placebo-indicating lack of efficacy of intranasal HC gp-39 treatment in the current setting. Safety variables were similar for all study groups. CONCLUSION: It was concluded that with the treatment protocol used (dose levels and frequency of dosing), intranasal treatment with Org 39141 was safe but did not result in more clinical improvement than in placebo-treated patients.


Subject(s)
Antirheumatic Agents/administration & dosage , Arthritis, Rheumatoid/drug therapy , Glycoproteins/administration & dosage , Lectins/administration & dosage , Adipokines , Administration, Intranasal , Antirheumatic Agents/adverse effects , Antirheumatic Agents/therapeutic use , Chitinase-3-Like Protein 1 , Double-Blind Method , Female , Glycoproteins/adverse effects , Glycoproteins/therapeutic use , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Lectins/adverse effects , Lectins/therapeutic use , Male , Middle Aged , Patient Compliance , Recombinant Proteins/administration & dosage , Recombinant Proteins/adverse effects , Recombinant Proteins/therapeutic use , Severity of Illness Index , Treatment Outcome
13.
Vet Res Commun ; 32 Suppl 1: S3-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18688753

ABSTRACT

This paper describes the nutritional aspects, including drinking water, that produce a negative influence on safety, health, nutritional and technological properties of food of animal origin, such as dairy and meat products, eggs, fish, and including processed and manufactured products. The purpose was to define an overview concerning the main aspects of food safety and to produce guidelines that best fit the different breeding systems, aiming to prevent health risk to consumers from fraudulent practices that should be avoided with the application of current rules in animal husbandry.


Subject(s)
Animal Husbandry/standards , Breeding/standards , Cardiovascular Diseases/prevention & control , Food/standards , Meat/standards , Risk Management/methods , Alkaloids/adverse effects , Animals , Cholesterol, Dietary/adverse effects , Lectins/adverse effects , Plants, Toxic , Poultry
14.
Exp Neurol ; 213(2): 293-302, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18602393

ABSTRACT

We investigated the role that nonpeptidergic isolectin-B4 (IB4) positive, primary afferent sprouting plays in bladder dysfunction after spinal cord transection (SCT). Rats were implanted with an indwelling bladder cannula and subjected to a complete spinal cord transection at T9/T10. In one group of rats IB4-positive terminals increased below the level of the injury in L6 cord in laminae I and III-VI as early as 3 days after transection, and remained increased 8 and 21 days after transection. Growth associated protein 43 (Gap-43) was expressed on IB4-positive neurons 3 days post-transection and the number of L6 dorsal root ganglia (DRG) neurons expressing IB4 did not change after injury. In another set of experiments IB4-saporin or saporin alone was administered intrathecally to L6/S1 cord. IB4-positive afferents sprouted in L6 cord of saporin only treated rats but IB4 afferent labeling was decreased by 42 and 33% in L6 cord and DRG 21 days after IB4-saporin treatment. IB4-saporin treated rats voided with an efficiency of 28.3% 10-14 days after transection whereas one week later voiding efficiency increased to 86.1%. Inefficient voiding by saporin and 10-14 day IB4-saporin treated rats was linked to voiding that occurred after the peak in micturition pressure. On the other hand, increased voiding efficiency in 20-30 day IB4-saporin treated rats was associated with voiding occurring before the peak of the micturition pressure. These results suggest that IB4-positive afferent sprouting plays a role in the generation of bladder dysfunction following SCT.


Subject(s)
Lectins/adverse effects , Lectins/metabolism , Neurons, Afferent/metabolism , Ribosome Inactivating Proteins, Type 1/adverse effects , Ribosome Inactivating Proteins, Type 1/metabolism , Spinal Cord Injuries/metabolism , Urinary Bladder Diseases/metabolism , Animals , Catheters, Indwelling , Female , Lectins/administration & dosage , Lectins/genetics , Neurons, Afferent/drug effects , Neurons, Afferent/pathology , Rats , Rats, Wistar , Ribosome Inactivating Proteins, Type 1/administration & dosage , Ribosome Inactivating Proteins, Type 1/genetics , Saporins , Spinal Cord/drug effects , Spinal Cord/metabolism , Spinal Cord/pathology , Spinal Cord Injuries/pathology , Urinary Bladder/drug effects , Urinary Bladder/metabolism , Urinary Bladder/pathology , Urinary Bladder Diseases/pathology , Urination/drug effects , Urination/physiology
15.
Plant Foods Hum Nutr ; 60(3): 137-45, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16187017

ABSTRACT

This study compared the levels of antinutritional components and cytotoxic effect of extracts, from tepary (Phaseolus acutifolius) and common (Phaseolus vulgaris) beans. Antinutritional factors were evaluated by determining their effect on the viability of epithelial cells isolated from rat small intestine. The protein and carbohydrates content were similar in all the genotypes studied (20 and 60%, respectively). Common beans presented higher content of trypsin inhibitors, tannins and lectins than tepary beans. There was not a significant correlation between tannins and cooking time. However, water absorption and cooking time correlated significantly (p < 0.05). Considerable variation was observed in lectin activity (1302-18161 Ul/mg) of extracts from different beans. Tannins, lectins, trypsin inhibitors and fat content differed between bean varieties whereas protein content was similar. The percent cellularity on rat epithelial cells was significantly different among protein extracts from different bean cultivars and ranged between 53.5% and 87.4% (p < 0.05). These results suggest that the incorporation of tepary beans in the diet would not alter the current nutritional contribution of common beans or introduce adverse toxic effects. The agronomic characteristics of tepary beans make them attractive for cultivation. However, the harder to cook phenomenon may be a limiting factor that needs further consideration.


Subject(s)
Lectins/analysis , Phaseolus/chemistry , Plant Extracts/adverse effects , Plant Extracts/analysis , Tannins/analysis , Trypsin Inhibitors/analysis , Animals , Cooking/methods , Epithelial Cells , Humans , Lectins/adverse effects , Nutritive Value , Phytohemagglutinins/adverse effects , Phytohemagglutinins/analysis , Rats , Species Specificity , Time Factors , Toxicity Tests , Water/metabolism
16.
Rev Invest Clin ; 57(1): 55-64, 2005.
Article in Spanish | MEDLINE | ID: mdl-15981959

ABSTRACT

Recently, there has been increased interest in the potential health benefits of plant lectins, particularly due to their anticancer effect. This updated review discusses literature data published on the anticancer activities of plant lectins and their possible molecular mechanism(s) of action.


Subject(s)
Lectins/therapeutic use , Neoplasms/drug therapy , Drug Screening Assays, Antitumor , Humans , Lectins/adverse effects
17.
Rev. invest. clín ; 57(1): 55-64, ene.-feb. 2005. tab
Article in Spanish | LILACS | ID: lil-632440

ABSTRACT

Recently, there has been increased interest in the potential health benefits of plant lectins, particularly due to their anti-cancer effect. This updated review discusses literature data published on the anticancer activities of plant lectins and their possible molecular mechanism(s) of action.


La importancia de estudiar compuestos naturales para utilizarlos como opciones médicas terapéuticas, específicamente contra el cáncer, nos da la pauta para realizar una revisión exhaustiva de la literatura concerniente a la actividad biológica de las lectinas vegetales, las cuales han sido reportadas por poseer propiedades tóxicas, citotóxicas, antitumorales y anticancerígenas. En este trabajo revisamos diferentes estudios publicados sobre el mecanismo de acción de las lectinas con respecto a su efecto antitumoral.


Subject(s)
Humans , Lectins/therapeutic use , Neoplasms/drug therapy , Drug Screening Assays, Antitumor , Lectins/adverse effects
18.
Forsch Komplementarmed Klass Naturheilkd ; 11 Suppl 1: 18-22, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15353898

ABSTRACT

BACKGROUND: Two examples of clinical research with mistletoe extracts were used to demonstrate essential difficulties in carrying out randomized and placebo-controlled trials. STUDY 1: In a randomized, placebo-controlled, double-blind study investigating the immunological effects of mistletoe extract, healthy subjects were asked to state whether, in their estimation, they had been treated with verum or a placebo. Due to the intrinsic effects of the mistletoe therapy--local inflammatory reactions at the injection site--100% of the subjects treated with verum and 77% of those treated with a placebo made a correct assessment of their therapy. Although double-blind trials are preferable from the methodological point of view--above all in QoL research--this study shows that double blinding is barely achievable when the investigated therapy has obvious (side) effects. STUDY 2: A prospective, randomized, multicenter study of a mistletoe therapy complementary to chemotherapy treatment of breast cancer had to be stopped after a period of 28 months, because it proved impossible to recruit more than 16 patients in six large study centers. With regard to this example and to other failed, GCP-compliant clinical trials on mistletoe therapy we describe which factors interfere with successful clinical trials. One important point, especially in the investigation of complementary cancer treatments, is that cancer patients are unwilling to have their treatment determined by randomization. Many cancer patients in Germany have their own point of view, as to whether a complementary treatment could be of benefit to them or not. Faced with a life-threatening disease they wish to determine this part of their treatment themselves. CONCLUSION: This background elucidates the need for improving the methodology of non-randomized trials to obtain objective and reliable results even in these fields of clinical research.


Subject(s)
Mistletoe , Phytotherapy , Plant Extracts/adverse effects , Plant Extracts/therapeutic use , Randomized Controlled Trials as Topic/methods , Breast Neoplasms/drug therapy , Complementary Therapies , Double-Blind Method , Humans , Lectins/adverse effects , Lectins/therapeutic use , Research Design
19.
Arch Pharm Res ; 27(1): 68-76, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14969342

ABSTRACT

Mistletoe lectin has been reported to induce apoptosis in different cancer cell lines in vitro and to show antitumor activity against a variety of tumors in animal models. We previously demonstrated the Korean mistletoe lectin (Viscum album var. coloratum, VCA)-induced apoptosis by down-regulation of Bcl-2 and telomerase activity and by up-regulation of Bax through p53- and p21-independent pathway in hepatoma cells. In the present study, we observed the induction of apoptotic cell death through activation of caspase-3 and the inhibition of telomerase activity through transcriptional down-regulation of hTERT in the VCA-treated A253 cells. We also observed the inhibition of telomerase activity and induction of apoptosis resulted from dephosphorylation of Akt in the survival signaling pathways. In addition, combining VCA with the inhibitors of phosphatidylinositol 3-kinase (PI3-kinase) upstream of Akt, wortmannin and LY294002 showed an additive inhibitory effect of telomerase activity. In contrast, the inhibitor of protein phosphatase 2A (PP2A), okadaic acid inhibited VCA-induced dephosphorylation of Akt and inhibition of telomerase activity. Taken together, VCA induces apoptotic cell death through Akt signaling pathway in correlated with the inhibition of telomerase activity and the activation of caspase-3. From these results, together with our previous studies, we suggest that VCA triggers molecular changes that resulting in the inhibition of cell growth and the induction of apoptotic cell death of cancer cells, which suggest that VCA may be useful as chemotherapeutic agent for cancer cells.


Subject(s)
Apoptosis , Cell Line, Tumor , Lectins/adverse effects , Lectins/chemistry , Mistletoe/chemistry , Phosphatidylinositol 3-Kinases/metabolism , Telomerase/antagonists & inhibitors , Caspase 3 , Caspases/adverse effects , Caspases/metabolism , Cell Survival/drug effects , Chromones/pharmacology , Drug Screening Assays, Antitumor/methods , Drug Synergism , Humans , Korea , Lectins/antagonists & inhibitors , Lectins/isolation & purification , Morpholines/pharmacology , Phosphatidylinositol 3-Kinases/pharmacology , Phosphoinositide-3 Kinase Inhibitors , Phosphoric Monoester Hydrolases/antagonists & inhibitors , Phosphoric Monoester Hydrolases/pharmacology , Phosphorylation/drug effects , Plant Extracts/chemistry , Plant Preparations/adverse effects , Plant Preparations/antagonists & inhibitors , Plant Preparations/chemistry , Plant Proteins/adverse effects , Plant Proteins/antagonists & inhibitors , Plant Proteins/chemistry , Ribosome Inactivating Proteins, Type 2 , Telomerase/genetics , Toxins, Biological/adverse effects , Toxins, Biological/chemistry , Up-Regulation
20.
Br J Nutr ; 88 Suppl 3: S307-19, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12498631

ABSTRACT

Pulses supply many bioactive substances found in minor amounts in food, but which may have significant metabolic and/or physiological effects. These compounds have long been classified as antinutritional factors, but many studies have reconsidered their impact on health. Some could play a role in the prevention of the major diseases of affluent societies. As these compounds can be beneficial or adverse, depending on conditions, an assessment of their various physiological effects is necessary to determine whether they should be preserved or eliminated in each main nutritional situation.


Subject(s)
Fabaceae/chemistry , Isoflavones , Alkaloids/administration & dosage , Alkaloids/adverse effects , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Blood Glucose/analysis , Calcium/metabolism , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/adverse effects , Estrogens, Non-Steroidal/administration & dosage , Estrogens, Non-Steroidal/adverse effects , Female , Flavonoids/administration & dosage , Flavonoids/adverse effects , Humans , Hydroxybenzoates/administration & dosage , Hydroxybenzoates/adverse effects , Lectins/administration & dosage , Lectins/adverse effects , Oxalates/administration & dosage , Oxalates/adverse effects , Phytic Acid/administration & dosage , Phytic Acid/adverse effects , Phytoestrogens , Phytohemagglutinins/administration & dosage , Phytohemagglutinins/adverse effects , Plant Preparations , Saponins/administration & dosage , Saponins/adverse effects , Tannins/administration & dosage , Tannins/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...